Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas. more
Time Frame | OMCL | Sector | S&P500 |
---|---|---|---|
1-Week Return | -2.24% | -2.12% | -3% |
1-Month Return | 7.56% | -3.42% | -0.73% |
3-Month Return | 0.81% | -11.13% | 2.87% |
6-Month Return | 59.16% | -5.74% | 7.17% |
1-Year Return | 18.59% | 3.97% | 25.31% |
3-Year Return | -74.23% | 1.05% | 28.38% |
5-Year Return | -45.19% | 34.37% | 81.89% |
10-Year Return | 36.01% | 97.88% | 183.27% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 897.03M | 892.21M | 1.13B | 1.30B | 1.15B | [{"date":"2019-12-31","value":69.22,"profit":true},{"date":"2020-12-31","value":68.85,"profit":true},{"date":"2021-12-31","value":87.35,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.52,"profit":true}] |
Cost of Revenue | 460.12M | 478.92M | 577.37M | 706.96M | 650.27M | [{"date":"2019-12-31","value":65.08,"profit":true},{"date":"2020-12-31","value":67.74,"profit":true},{"date":"2021-12-31","value":81.67,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.98,"profit":true}] |
Gross Profit | 436.91M | 413.29M | 554.65M | 588.99M | 496.84M | [{"date":"2019-12-31","value":74.18,"profit":true},{"date":"2020-12-31","value":70.17,"profit":true},{"date":"2021-12-31","value":94.17,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":84.36,"profit":true}] |
Gross Margin | 48.71% | 46.32% | 49.00% | 45.45% | 43.31% | [{"date":"2019-12-31","value":99.41,"profit":true},{"date":"2020-12-31","value":94.54,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":92.76,"profit":true},{"date":"2023-12-31","value":88.4,"profit":true}] |
Operating Expenses | 358.56M | 377.77M | 465.15M | 591.31M | 531.71M | [{"date":"2019-12-31","value":60.64,"profit":true},{"date":"2020-12-31","value":63.89,"profit":true},{"date":"2021-12-31","value":78.66,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":89.92,"profit":true}] |
Operating Income | 78.35M | 35.53M | 89.51M | (2.32M) | (34.87M) | [{"date":"2019-12-31","value":87.54,"profit":true},{"date":"2020-12-31","value":39.69,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-2.6,"profit":false},{"date":"2023-12-31","value":-38.96,"profit":false}] |
Total Non-Operating Income/Expense | (8.84M) | (12.35M) | (47.00M) | (260.00K) | 27.52M | [{"date":"2019-12-31","value":-32.12,"profit":false},{"date":"2020-12-31","value":-44.9,"profit":false},{"date":"2021-12-31","value":-170.82,"profit":false},{"date":"2022-12-31","value":-0.94,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | 73.93M | 29.35M | 66.01M | (2.45M) | (20.11M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":39.7,"profit":true},{"date":"2021-12-31","value":89.28,"profit":true},{"date":"2022-12-31","value":-3.32,"profit":false},{"date":"2023-12-31","value":-27.2,"profit":false}] |
Income Taxes | 12.60M | (2.85M) | (11.84M) | (8.10M) | 263.00K | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-22.59,"profit":false},{"date":"2021-12-31","value":-94.02,"profit":false},{"date":"2022-12-31","value":-64.32,"profit":false},{"date":"2023-12-31","value":2.09,"profit":true}] |
Income After Taxes | 61.34M | 32.19M | 77.85M | 5.65M | (20.37M) | [{"date":"2019-12-31","value":78.79,"profit":true},{"date":"2020-12-31","value":41.35,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":7.26,"profit":true},{"date":"2023-12-31","value":-26.17,"profit":false}] |
Income From Continuous Operations | 61.34M | 32.19M | 77.85M | 5.65M | (34.40M) | [{"date":"2019-12-31","value":78.79,"profit":true},{"date":"2020-12-31","value":41.35,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":7.26,"profit":true},{"date":"2023-12-31","value":-44.19,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 61.34M | 32.19M | 77.85M | 5.65M | (20.37M) | [{"date":"2019-12-31","value":78.79,"profit":true},{"date":"2020-12-31","value":41.35,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":7.26,"profit":true},{"date":"2023-12-31","value":-26.17,"profit":false}] |
EPS (Diluted) | 2.81 | 2.54 | 3.80 | 3.00 | 1.91 | [{"date":"2019-12-31","value":73.95,"profit":true},{"date":"2020-12-31","value":66.84,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":78.95,"profit":true},{"date":"2023-12-31","value":50.26,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
OMCL | |
---|---|
Cash Ratio | 0.61 |
Current Ratio | 1.05 |
Quick Ratio | 0.95 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
OMCL | |
---|---|
ROA (LTM) | -0.87% |
ROE (LTM) | -1.46% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
OMCL | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.47 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.53 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
OMCL | |
---|---|
Trailing PE | NM |
Forward PE | 29.50 |
P/S (TTM) | 1.96 |
P/B | 1.69 |
Price/FCF | 221 |
EV/R | 1.99 |
EV/Ebitda | 37.88 |
PEG | 2.28 |
Omnicell Inc (OMCL) share price today is $44.98
Yes, Indians can buy shares of Omnicell Inc (OMCL) on Vested. To buy Omnicell Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in OMCL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Omnicell Inc (OMCL) via the Vested app. You can start investing in Omnicell Inc (OMCL) with a minimum investment of $1.
You can invest in shares of Omnicell Inc (OMCL) via Vested in three simple steps:
The 52-week high price of Omnicell Inc (OMCL) is $55.74. The 52-week low price of Omnicell Inc (OMCL) is $25.12.
The price-to-earnings (P/E) ratio of Omnicell Inc (OMCL) is
The price-to-book (P/B) ratio of Omnicell Inc (OMCL) is 1.69
The dividend yield of Omnicell Inc (OMCL) is 0.00%
The market capitalization of Omnicell Inc (OMCL) is $2.05B
The stock symbol (or ticker) of Omnicell Inc is OMCL